Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies

Neurology

Volumn 88, Issue 2, 2017, Pages 198-208

  Deckers, Kay ^a   Camerino, Ileana ^a,b   Van Boxtel, Martin P J ^a   Verhey, Frans R J ^a   Irving, Kate ^c   Brayne, Carol ^d   Kivipelto, Miia ^e   Starr, John M ^f   Yaffe, Kristine ^g   De Leeuw, Peter W ^h,i   Köhler, Sebastian ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DUBLIN CITY UNIVERSITY   (Ireland)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ Zuyderland Medical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

ALBUMINURIA; ARTICLE; COGNITIVE DEFECT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEMENTIA; ESTIMATED GLOMERULAR FILTRATION RATE; FOLLOW UP; HUMAN; KIDNEY DISEASE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW; AGED; BIBLIOGRAPHIC DATABASE; KIDNEY DISEASES; META ANALYSIS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DATABASES, BIBLIOGRAPHIC; DEMENTIA; HUMANS; KIDNEY DISEASES; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85009152018     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003482     Document Type: Article

References (60)

1. Deckers K, van Boxtel MP, Schiepers OJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 2015; 30:234-246.
2. Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial 2008;21:29-37.
3. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 2008;15:123-132.
4. Mogi M, Horiuchi M. Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract 2011; 2011:306189.
5. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011;10:819-828.
6. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM. Kidney function is related to cerebral small vessel disease. Stroke 2008;39:55-61.
7. Rajagopalan P, Refsum H, Hua X, et al. Mapping creatinineand cystatin C-related white matter brain deficits in the elderly. Neurobiol Aging 2013;34:1221-1230.
8. Seliger SL, Sarnak MJ. Subclinical vascular disease of the brain in dialysis patients. Am J Kidney Dis 2007; 50:8-10.
9. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 2013;24: 353-363.
10. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. The Lancet 2005; 366:2112-2117.
11. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 2014;13: 788-794.
12. Plassman BL, Williams JW, Jr. , Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 2010;153:182-193.
13. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382:260-272.
14. World Health Organization. Dementia: A Public Health Priority. Geneva: WHO; 2012.
15. Tonelli M, Riella M. Chronic kidney disease and the ageing population. Lancet 2014;383:1278-1279.
16. Etgen T, Chonchol M, Forstl H, Sander D. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 2012;35:474-482.
17. Traynor J, Mactier R, Geddes CC, Fox JG. How to measure renal function in clinical practice. BMJ 2006;333: 733-737.
18. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa: Ottawa Hospital Research Institute; 2000.
19. O'Riordan P, Stevens PE, Lamb EJ. Estimated glomerular filtration rate. BMJ 2014;348:g264.
20. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
21. Browne OT, Bhandari S. Interpreting and investigating proteinuria. BMJ 2012;344.
22. Barzilay JI, Gao P, O'Donnell M, et al. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Intern Med 2011;171:142-150.
23. Chavan VU, Sayyed AK, Durgawale PP, Sontakke AV, Nilakhe SD. Practical aspects of calculation, expression and interpretation of urine albumin measurement. NJIRM 2011;2:29-34.
24. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 1999;33:1004-1010.
25. Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004;41:467-550.
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
28. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250.
29. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 2009;73: 920-927.
30. Darsie B, Shlipak MG, Sarnak MJ, Katz R, Fitzpatrick AL, Odden MC. Kidney function and cognitive health in older adults: the Cardiovascular Health Study. Am J Epidemiol 2014;180:68-75.
31. Feng L, Yap KB, Yeoh LY, Ng TP. Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study. J Am Geriatr Soc 2012;60:1208-1214.
32. KhatriM, Nickolas T,Moon YP, et al. CKD associates with cognitive decline. J Am Soc Nephrol 2009;20:2427-2432.
33. Wang F, Zhang L, Liu L, Wang H. Level of kidney function correlates with cognitive decline. Am J Nephrol 2010; 32:117-121.
34. Davey A, Elias MF, Robbins MA, Seliger SL, Dore GA. Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant 2013;28: 1810-1819.
35. Helmer C, Stengel B, Metzger M, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 2011;77:2043-2051.
36. Jassal SK, Kritz-Silverstein D, Barrett-Connor E. A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol 2010;171:277-286.
37. Lipnicki DM, Sachdev PS, Crawford J, et al. Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study. PLoS One 2013;8:e65841.
38. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J. Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol 2012;7:437-443.
39. Seliger SL, Wendell CR, Waldstein SR, Ferrucci L, Zonderman AB. Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging. Am J Nephrol 2015;41:305-312.
40. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005;16:2127-2133.
41. Etgen T, Sander D, Chonchol M, et al. Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study. Nephrol Dial Transplant 2009;24:3144-3150.
42. Kurella Tamura M, Muntner P, Wadley V, et al. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis 2011;58:756-763.
43. Slinin Y, Paudel ML, Ishani A, et al. Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc 2008;56:2082-2088.
44. Slinin Y, Peters KW, Ishani A, et al. Cystatin C and cognitive impairment 10 years later in older women. J Gerontol A Biol Sci Med Sci 2015;70:771-778.
45. O'Hare AM, Walker R, Haneuse S, et al. Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc 2012;60:2215-2222.
46. Sasaki Y, Marioni R, Kasai M, Ishii H, Yamaguchi S, Meguro K. Chronic kidney disease: a risk factor for dementia onset: a population-based study: The Osaki-Tajiri Project. J Am Geriatr Soc 2011;59: 1175-1181.
47. Higuchi M, Chen R, Abbott RD, et al. Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia Aging Study. Alzheimer Dis Assoc Disord 2015;29:200-205.
48. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol 2004;15:1904-1911.
49. Yaffe K, Lindquist K, Shlipak MG, et al. Cystatin C as a marker of cognitive function in elders: findings from the Health ABC Study. Ann Neurol 2008;63:798-802.
50. Sundelöf J, Arnlov J, Ingelsson E, et al. Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology 2008;71:1072-1079.
51. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis 2007;49:A6-A7, S1-S296.
52. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke 1997;28:557-563.
53. Ishimura E, Shoji T, Emoto M, et al. Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis 2001;38:S186-S190.
54. Miwa K, Tanaka M, Okazaki S, et al. Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology 2014;82:1051-1057.
55. Sastre M, Calero M, Pawlik M, et al. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging 2004;25: 1033-1043.
56. Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci USA 1986;83:2974-2978.
57. Riverol M, Becker JT, Lopez OL, et al. Relationship between systemic and cerebral vascular disease and brain structure integrity in normal elderly individuals. J Alzheimers Dis 2015;44:319-328.
58. Zhong XM, Hou L, Luo XN, et al. Alterations of CSF cystatin C levels and their correlations with CSF Alphabeta40 and Alphabeta42 levels in patients with Alzheimer's disease, dementia with Lewy bodies and the atrophic form of general paresis. PLoS One 2013;8:e55328.
59. De Deyn PP, Vanholder R, Eloot S, Glorieux G. Guanidino compounds as uremic (neuro)toxins. Semin Dial 2009;22:340-345.
60. Nagai A, Ryu JK, Terashima M, et al. Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B. Brain Res 2005; 1066:120-128.